The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+12.2% to $52.40
Predicted High$52.40at 6 months
Predicted Low$45.40at 1 month
Max Drawdown (predicted)-2.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 14, 2026 3:26 am
Bull
NVO trends higher to
$52.40
(+12.2% from $46.72)
by Feb 2027.
dip-then-recover
ThesisNVO trades at a discount to fair value but sentiment is deeply negative as GLP-1 mindshare rotates to Lilly. Expect near-term drift lower or flat as narrative headwinds dominate, then gradual mean-reversion toward the composite fair value as valuation gravity and prior earnings-beat cadence reassert. Endpoint lands modestly below the deterministic baseline given sentiment drag.
Invalidated ifBreak below the $42 attractive-value line on sustained volume, or Lilly headline that structurally cuts NVO GLP-1 share estimates
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $46.72 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 14, 2026
—
$46.72at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 28, 2026
$43.14–$50.30typical range · internal point $46.10
—
±7.7%
6/10
Sentiment drag persists, no catalyst, mild drift lower
1 month
Sep 14, 2026
$41.53–$51.91typical range · internal point $45.40
—
±11.1%
6/10
GLP-1 narrative rotation to Lilly continues weighing
2 months
Oct 14, 2026
$45.90
—
-1.8%
5/10
Value buyers begin nibbling near bear scenario floor
3 months
Nov 14, 2026
$48.50
—
+3.8%
5/10
Earnings likely in window, beat cadence supports bounce
4 months
Dec 14, 2026
$50.20
—
+7.4%
4/10
Post-print stabilization, valuation gravity kicks in
5 months
Jan 14, 2027
$51.50
—
+10.2%
4/10
Gradual convergence toward composite fair value
6 months
Feb 14, 2027
$52.40
—
+12.2%
4/10
Mean reversion toward baseline, sentiment partially fades
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$53.47
(+14.4%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.